Laboratoire SONAS, EA 921, IFR QUASAV 149, Université d'Angers, UFR Sciences Pharmaceutiques et Ingénierie de la Santé, 16 Boulevard Daviers, 49045 Angers cedex 01, France.
J Inorg Biochem. 2010 Apr;104(4):397-404. doi: 10.1016/j.jinorgbio.2009.11.012. Epub 2009 Dec 3.
The reaction of zinc(II) chloride, cadmium(II) chloride and bromide with 3-thiophene aldehyde thiosemicarbazone leads to the formation of a series of new complexes. They have been characterized by spectroscopic studies: infrared, (1)H NMR, and electronic spectra. The crystal structures of the compound [ZnCl(2)(3TTSCH)(2)] and [CdBr(2)(3TTSCH)(2)] have been determined by X-ray diffraction methods. For the complexes [ZnCl(2)(3TTSCH)(2)] and [CdBr(2)(3TTSCH)(2)], the central ion is coordinated through the sulfur, and for the complexes [CdCl(2)(3TTSCH)], [CdBr(2)(3TTSCH)] the ion is coordinated through the sulfur as well as azomethine nitrogen atom of the thiosemicarbazone. In addition, fungistatic and bacteriostatic activities of both ligand and complexes have been evaluated. Cadmium(II) complexes have shown the most significant activities.
锌(II) 氯化物、镉(II) 氯化物和溴化物与 3-噻吩甲醛缩氨硫脲反应生成了一系列新的配合物。通过光谱研究:红外、(1)H NMR 和电子光谱对其进行了表征。通过 X 射线衍射方法确定了化合物 [ZnCl2(3TTSCH)2] 和 [CdBr2(3TTSCH)2] 的晶体结构。对于配合物 [ZnCl2(3TTSCH)2] 和 [CdBr2(3TTSCH)2],中心离子通过硫原子配位,对于配合物 [CdCl2(3TTSCH)] 和 [CdBr2(3TTSCH)],离子通过硫原子以及缩氨硫脲的亚甲氮原子配位。此外,还评估了配体和配合物的抑菌和杀菌活性。镉(II) 配合物表现出最显著的活性。